Can Sana Biotechnology's (SANA) Pipeline Momentum Translate into More Share Price Upside?

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to buy right now. The company develops next-generation cell and gene therapies, including ex vivo engineered cells and in vivo delivery technologies.

Its focus is on creating medicines that can repair or control genes and replace damaged cells. Still in early clinical stages, Sana Biotechnology Inc. (NASDAQ:SANA) represents the frontier of regenerative medicine, with transformative potential but significant development risk.

Following the company’s second-quarter 2025 results on August 11, H.C. Wainwright analyst Emily Bodnar reaffirmed a Buy rating on Sana Biotechnology (NASDAQ:SANA) with a price target of $11.

Bodnar pointed to encouraging progress in the company’s UP421 program, which demonstrated islet cell survival and function in type 1 diabetes patients without immunosuppression, an important proof point for Sana’s hypoimmune (HIP) platform.

The analyst also highlighted that, in parallel, the company is advancing SC451, a one-time iPSC-derived HIP-modified islet cell therapy, supported by positive feedback from a pre-IND FDA INTERACT meeting that lays the groundwork for an IND filing in 2026.

Financially, Sana’s balance sheet is strong (cash position of around $177 million) and provides a good runway to pursue these development milestones. Bodnar emphasized that the scalability and immunosuppression-free profile of SC451 position it for a significant market opportunity.

Sana Biotechnology (NASDAQ:SANA) is a clinical-stage biotechnology company focused on creating and delivering engineered cells as a form of medicine.

While we acknowledge the potential of SANA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Best Stocks For Day Trading: 12 Stock Picks and 15 Best Multibagger Stocks to Invest in Right Now.

Disclosure: None. This article is originally published at Insider Monkey.